Zydus Lifesciences Buyback of ā¹1,100 crores approved by the board of directors at the meeting held on May 19, 2026. Zydus Lifesciences Buyback will be done via the Tender Offer route through the stock exchange mechanism. The board of directors of the company approved the buyback by the Company of its fully paid-up equity shares having a face value of ā¹1 each equity share at a price of ā¹1260 per Equity Share and for an aggregate amount not exceeding ā¹1,100 crores from the shareholders. Check out Zydus Lifesciences Buyback 2026 details below:
Zydus Lifesciences Buyback About us
Zydus Lifesciences Limited is one of the leading pharmaceutical companies in India. With 70 years of experience in the pharma industry, the firm has built a reputation for offering innovative and effective pharmaceutical solutions. They offer everything, from formulating active pharmaceutical ingredients, animal healthcare products, to wellness products.
Incorporated in 1952 by Mr. Ramanbhai B. Patel with a dream to build a pharmaceutical company that delivers high-quality and affordable pharmaceutical products. Its product portfolio includes Animal Healthcare, Generic Medicines, APIs, Vaccines, and many more. Along with national, it also has a wide international presence across Algeria, Brazil, France, Myanmar, and the Philippines.
Zydus Lifesciences Buyback History
- N/A
Zydus Lifesciences Buyback 2026 Dates
| Buyback Meeting Date: | May 19, 2026 |
| Buyback Announcement Date: | May 19, 2026 |
| Buyback Record Date: | May 29, 2026 |
| Last Date to Buy Shares: | May 27, 2026 |
| Buyback Open Date: | June 4, 2026 |
| Buyback Close Date: | June 10, 2026 |
| Finalization of Buyback Acceptance: | June 16, 2026 |
Zydus Lifesciences Buyback 2026 Offer Details
Zydus Lifesciences Buyback ofĀ 87,30,158 equity shares at a price of ā¹1260 per equity share. The buyback offers not to exceed ā¹1100 crores of the total buyback offer size.
| Offer Amount: | ā¹1100 Crores |
| Number of Shares: | 87,30,158 Equity Shares |
| Face Value: | ā¹1Ā per equity share |
| Buyback Price: | ā¹1260 per equity share |
| Listing: | BSE, NSE |
| Buyback Type: | Tender Offer |
| Letter of Offer: | Click Here |
Zydus Lifesciences Buyback 2026 Acceptance Ratio
The investor should buy around 87,30,158 shares at a current market price of ā¹1082 (as of May 29). The calculation will be ā¹2,00,000 / ā¹1260 buyback price = 159 shares.
| Acceptance Ratio | Investment | Shares Buyback | Profit |
| 33% | ā¹1,72,038 | 52 | ā¹9,340 |
| 50% | ā¹1,72,038 | 80 | ā¹14,151 |
| 75% | ā¹1,72,038 | 119 | ā¹21,227 |
| 100% | ā¹1,72,038 | 159 | ā¹28,254 |
Zydus Lifesciences Financial Report
| ā¹ in Crores | |||
| Year | Revenue | Expense | PAT |
| 2023 | ā¹9,280.00 | ā¹7,044.00 | ā¹1,529.20 |
| 2024 | ā¹11,903.50 | ā¹7,655.10 | ā¹3,441.50 |
| 2025 | ā¹15,812.50 | ā¹8,367.80 | ā¹5,774.90 |
How to Participate in Zydus Lifesciences Buyback 2026
The investors, who have Zydus Lifesciences Buyback shares in their Demat Account as of the Record Date, are eligible for the buyback scheme. Eligible Shareholders can participate in the Zydus Lifesciences Buyback 2026 scheme as per the opening form by selling their shares. The payment will be given as per the Zydus Lifesciences Buyback accepted shares by the company under the Zydus Lifesciences Buyback scheme.
Zydus Lifesciences Buyback 2026 Registrar
MUFG Intime India Pvt. Ltd.
Phone: +91-22-4918 6270
Email: [email protected]
Website: https://in.mpms.mufg.com/Initial_Offer/public-issues.html
Zydus Lifesciences Buyback 2026 Lead Managers
- To be updated soon
Zydus Lifesciences Company Address
Zydus Lifesciences Limited
Zydus Corporate Park, Scheme No. 63, Survey No. 536,
Khoraj (Gandhinagar), Nr. Vaishnodevi Circle,
S. G. Highway, Ahmedabad-382 481,
Gujarat, India.
Phone: +91-79-71800000
Email: [email protected]
Website: https://www.zyduslife.com/
